Acute Upper Respiratory Tract Infection Clinical Trial
Official title:
Non-antibiotic Prescribing for Acute Upper Respiratory Tract Infection：a Randomized-control Trial
Some acute upper respiratory tract infection(AURI) in children is characterized by fever and vomiting,and it is one common reason for visiting a pediatrician. White blood count(WBC) usually increased in this children patients,hence antibiotics are often prescribed properly assumed. In the present study, it was hypothesized that it was not necessary to prescribe amoxicillin for the children.
After inclusion of eligible children patients,one group was prescribed amoxicillin,and another not. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01537081 -
Safety and Efficacy of Mucinex and IR Guaifenesin the Treatment of Symptoms of Acute Upper Respiratory Tract Infections
|
Phase 2/Phase 3 | |
| Completed |
NCT05879393 -
The Multistrain Probiotic OMNi-BiOTiC® Active for Upper Respiratory Tract Infections in Older People
|
N/A | |
| Completed |
NCT04611061 -
Kagocel® for the Prevention of ARVI and Influenza in Adults Health Care Workers
|
||
| Recruiting |
NCT03827590 -
Clinical Trials to Assess the Efficacy and Safety of HLIM
|
Phase 3 | |
| Completed |
NCT05134766 -
Retrospective Evaluation of Clinical, Virological and Serological Data in Patients With Mild Acute Upper Respiratory Tract Infections
|
||
| Not yet recruiting |
NCT03218696 -
Comparison of a Protective Cough Syrup Against Placebo on Night Cough in Children 1-5 Years Coughing Since 1- 2 Days Due to Common Cold
|
N/A | |
| Completed |
NCT04626622 -
Kagocel® for the Prevention of ARVI and Influenza in Young People
|
||
| Completed |
NCT05214677 -
A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of DW1809
|
Phase 1 | |
| Completed |
NCT05214690 -
A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of DW1809-T2
|
Phase 1 |